Published in Wound Repair Regen on August 30, 2007
Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers | NCT01686139
Factors affecting wound healing. J Dent Res (2010) 5.67
Cardiac fibroblast: the renaissance cell. Circ Res (2009) 4.01
Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res (2009) 3.25
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells (2009) 2.68
Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells (2010) 1.78
Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. Diabetes (2014) 1.49
Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease. Dig Dis Sci (2013) 1.44
Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis. Dig Dis Sci (2015) 1.44
Practices in wound healing studies of plants. Evid Based Complement Alternat Med (2011) 1.36
Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther (2010) 1.29
Mesenchymal stem cells induce dermal fibroblast responses to injury. Exp Cell Res (2009) 1.23
Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell (2011) 1.21
Wound healing and blastema formation in regenerating digit tips of adult mice. Dev Biol (2010) 1.17
Characterization of the early proliferative response of the rodent bladder to subtotal cystectomy: a unique model of mammalian organ regeneration. PLoS One (2012) 1.03
Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells (2011) 0.97
Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle) (2015) 0.97
The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol (2009) 0.93
Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater (2011) 0.93
Treadmill running exercise results in the presence of numerous myofibroblasts in mouse patellar tendons. J Orthop Res (2009) 0.92
HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells. Stem Cells (2009) 0.90
Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model. Stem Cell Res Ther (2014) 0.89
Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies. J Cell Mol Med (2009) 0.88
Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. J Immunol (2015) 0.88
Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. PLoS One (2014) 0.87
Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model. J Biomed Sci (2013) 0.87
In vivo multimodal microscopy for detecting bone-marrow-derived cell contribution to skin regeneration. J Biophotonics (2013) 0.86
Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell Biol (2011) 0.86
Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury. J Spinal Cord Med (2011) 0.86
Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol (2012) 0.86
Comparison of enzymatic and non-enzymatic means of dissociating adherent monolayers of mesenchymal stem cells. Biol Proced Online (2009) 0.86
Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats. J Diabetes Res (2013) 0.84
Marrow-derived stromal cell delivery on fibrin microbeads can correct radiation-induced wound-healing deficits. J Invest Dermatol (2012) 0.84
Detection of endothelial progenitor cells in human skin wounds and its application for wound age determination. Int J Legal Med (2015) 0.84
Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening. Stem Cells Dev (2013) 0.83
Microchimeric fetal cells play a role in maternal wound healing after pregnancy. Chimerism (2014) 0.82
A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin wounds. Tissue Eng Part C Methods (2011) 0.81
The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med (2009) 0.81
Cellular mechanisms of skin repair in humans and other mammals. J Cell Commun Signal (2016) 0.81
Imaging and tracking of bone marrow-derived immune and stem cells. Methods Mol Biol (2013) 0.80
Efficacy of microneedling plus human stem cell conditioned medium for skin rejuvenation: a randomized, controlled, blinded split-face study. Ann Dermatol (2014) 0.80
Mesenchymal stem cells derived from breast cancer tissue promote the proliferation and migration of the MCF-7 cell line in vitro. Oncol Lett (2013) 0.80
Stem Cells for Cutaneous Wound Healing. Biomed Res Int (2015) 0.79
Adipose stromal cells repair pressure ulcers in both young and elderly mice: potential role of adipogenesis in skin repair. Stem Cells Transl Med (2015) 0.79
A novel method to apply osteogenic potential of adipose derived stem cells in orthopaedic surgery. PLoS One (2014) 0.79
The Effect of Bone-Marrow-Derived Stem Cells and Adipose-Derived Stem Cells on Wound Contraction and Epithelization. Adv Wound Care (New Rochelle) (2014) 0.78
Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody. Tissue Eng Part A (2014) 0.78
Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds. Organogenesis (2015) 0.77
Type I and II Diabetic Adipose-Derived Stem Cells Respond In Vitro to Dehydrated Human Amnion/Chorion Membrane Allograft Treatment by Increasing Proliferation, Migration, and Altering Cytokine Secretion. Adv Wound Care (New Rochelle) (2016) 0.76
Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts. Stem Cells Dev (2015) 0.76
Therapeutic Targeting of Telomerase. Genes (Basel) (2016) 0.76
Foetal stem cell derivation & characterization for osteogenic lineage. Indian J Med Res (2013) 0.75
Inhibition of Contractile Function in Human Joint Capsule Myofibroblasts by Targeting the TGF-β1 and PDGF Pathways. PLoS One (2016) 0.75
Autologous bone-marrow-derived-mononuclear-cells-enriched fat transplantation in breast augmentation: evaluation of clinical outcomes and aesthetic results in a 30-year-old female. Case Rep Surg (2013) 0.75
The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity. Eye (Lond) (2015) 0.75
Alleviation of skin inflammation after Lin(-) cell transplantation correlates with their differentiation into myeloid-derived suppressor cells. Sci Rep (2015) 0.75
Effects of a Novel Inoculation Method on Cell Distribution, Mineralization, and Vascularization of Tissue-Engineered Constructs. Adv Wound Care (New Rochelle) (2016) 0.75
MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells. Nat Mater (2016) 0.75
Inhibition of murine fibrocyte differentiation by cross-linked IgG is dependent on FcγRI. J Leukoc Biol (2014) 0.75
Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue. J R Soc Interface (2009) 0.75
TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed. Front Cell Dev Biol (2017) 0.75
Nitric oxide regulates cell behavior on an interactive cell-derived extracellular matrix scaffold. J Biomed Mater Res A (2015) 0.75
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83
Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest (2002) 2.05
Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol (2005) 1.88
Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells (2010) 1.78
Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol (2006) 1.66
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation (2005) 1.56
Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen (2007) 1.56
Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen (2005) 1.52
Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil (2005) 1.47
Toxic shock syndrome in an adult burn patient. Burns (2007) 1.39
Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol (2011) 1.36
The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc (2013) 1.32
Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One (2009) 1.31
Bladder outlet obstruction: progression from inflammation to fibrosis. BJU Int (2010) 1.28
Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest (2008) 1.22
Infection control in the burn unit. Burns (2010) 1.19
The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg (2008) 1.15
Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen (2007) 1.10
Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol (2007) 1.10
Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol (2004) 1.10
Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol (2006) 1.09
Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine (2008) 1.07
Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflamm (Lond) (2010) 1.07
Novel mutations in the small leucine-rich repeat protein/proteoglycan (SLRP) genes in high myopia. Hum Mutat (2007) 1.03
Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem (2005) 1.01
Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen (2005) 1.01
The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J Trauma (2007) 0.99
Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor-beta1 transgenic mouse. Wound Repair Regen (2002) 0.99
Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen (2011) 0.98
Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem (2003) 0.98
The molecular mechanism of hypertrophic scar. J Cell Commun Signal (2013) 0.97
Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. J Interferon Cytokine Res (2007) 0.97
Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol (2004) 0.96
Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol (2005) 0.95
Quality-of-life and outcome predictors following massive burn injury. Plast Reconstr Surg (2005) 0.95
Characterization of opticin and evidence of stable dimerization in solution. J Biol Chem (2003) 0.93
Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res (2008) 0.93
Hypertrophic scar, wound contraction and hyper-hypopigmentation. J Burn Care Res (2007) 0.92
Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen (2011) 0.91
Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes. Tissue Eng Part A (2013) 0.90
Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J Cell Biochem (2003) 0.89
Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem (2006) 0.89
Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. J Burn Care Res (2012) 0.89
Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen (2004) 0.89
The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar postburn injury. J Burn Care Res (2012) 0.88
Protonation-mediated structural flexibility in the F conjugation regulatory protein, TraM. EMBO J (2006) 0.88
Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res (2006) 0.88
Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG). J Cell Physiol (2004) 0.88
Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-gamma-treated skin cells in a co-culture system. Wound Repair Regen (2003) 0.87
Dynamic signals for hair follicle development and regeneration. Stem Cells Dev (2011) 0.87
Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. Hum Immunol (2004) 0.87
Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol (2002) 0.86
Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring. J Burn Care Res (2012) 0.86
Scar and contracture: biological principles. Hand Clin (2009) 0.86
Review of burn injuries secondary to home oxygen. J Burn Care Res (2012) 0.86
Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials (2011) 0.86
Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system. J Invest Dermatol (2002) 0.84
A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen (2012) 0.84
Increased severity of bleomycin-induced skin fibrosis in mice with leukocyte-specific protein 1 deficiency. J Invest Dermatol (2008) 0.84
Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders. Tissue Eng Part A (2013) 0.84
Carotid rupture following electrical injury: a report of two cases. J Burn Care Res (2012) 0.84
Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen (2011) 0.83
Characterization of heterotopic ossification in burn patients. J Burn Care Res (2014) 0.82
Alterations in lymphocyte function and relation to phospholipid composition after burn injury in humans. Crit Care Med (2002) 0.82
De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold. In Vitro Cell Dev Biol Anim (2009) 0.82
Biochemical and immunohistochemical studies of the protein expression and localization of decorin and biglycan in the temporomandibular joint disc of growing rats. Arch Oral Biol (2002) 0.82
Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen (2007) 0.81
Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem (2002) 0.81
Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent. Wound Repair Regen (2002) 0.81
Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells. Wound Repair Regen (2013) 0.81
Differential expression of class I small leucine-rich proteoglycans in an animal model of partial bladder outlet obstruction. J Urol (2012) 0.81
Impaired cutaneous wound healing in transforming growth factor-β inducible early gene1 knockout mice. Wound Repair Regen (2012) 0.80
Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis. Methods Mol Biol (2013) 0.80
On the calculation of the binding force between decorin and collagen. J Biomech (2006) 0.79
The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo. Wound Repair Regen (2014) 0.79
Fluorescent-activated cell-sorting analysis of intracellular interferon-gamma and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen (2005) 0.79
Pathophysiology and management of the burn scar. Clin Plast Surg (2009) 0.79
Chimeras of bacterial translation factors Tet(O) and EF-G. FEBS Lett (2008) 0.79
Complications of chlorine inhalation in a pediatric chemical burn patient: a case report. J Burn Care Res (2012) 0.79
Does nanocrystalline silver have a transferable effect? Wound Repair Regen (2010) 0.79
Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res (2005) 0.78
The JCR:LA-cp rat: a novel model for impaired wound healing. Wound Repair Regen (2004) 0.78